Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$32.18 - $46.57 $11,230 - $16,252
-349 Reduced 88.13%
47 $2,000
Q2 2023

Jul 14, 2023

BUY
$31.86 - $67.26 $5,862 - $12,375
184 Added 86.79%
396 $17,000
Q1 2023

Apr 21, 2023

BUY
$45.44 - $74.26 $9,633 - $15,743
212 New
212 $13,000
Q3 2022

Nov 01, 2022

BUY
$72.36 - $113.1 $0 - $0
0 New
0 $0

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Harbor Investment Advisory, LLC Portfolio

Follow Harbor Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.